BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3524870)

  • 1. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
    Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
    Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
    [No Abstract]   [Full Text] [Related]  

  • 2. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 4. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
    Levin A
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients.
    Lehmann HE; Pecknold JC; Ban TA; Orbach L
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):463-8. PubMed ID: 816604
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
    Poelinger W; Haber H
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
    Singh AN; Saxena B; Gent M; Nelson HL
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
    [No Abstract]   [Full Text] [Related]  

  • 10. [A profile of the clinical effectiveness of second generation antidepressive agents].
    Kabes J; Dostal T; Balon R; Papezová H
    Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
    [No Abstract]   [Full Text] [Related]  

  • 11. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recurrence of unipolar depression and efficacy of maprotiline].
    Rouillon F; Phillips R; Serrurier D; Ansart E; Gérard MJ
    Encephale; 1989; 15(6):527-34. PubMed ID: 2693074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersensitivity and nomifensine in depressed patients.
    Montgomery S; Roy D; Montgomery DB
    Adv Biochem Psychopharmacol; 1982; 32():105-11. PubMed ID: 7046359
    [No Abstract]   [Full Text] [Related]  

  • 16. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depressive states, occurrence and treatment in family practice. Randomized study of the efficacy of maprotiline (Ludiomil) and flupenthixol (Fluanxol)].
    Sederberg-Olsen P; Lauritsen B; Husfeldt P; Rønne H; Ekstrøm K; Bjørndal F; Holst B; Jakobsen K
    Ugeskr Laeger; 1981 May; 143(22):1383-7. PubMed ID: 7027568
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 19. [A double-blind comparison study of nomifensine and imipramine in treating depressed patients].
    Wang XJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):73-6, 125. PubMed ID: 2791759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors which affect antidepressant drug responses in a multicenter controlled trial [proceedings].
    Logue JN; Sachais BA
    Psychopharmacol Bull; 1981 Jan; 17(1):138-9. PubMed ID: 7015395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.